Compare BridgeBio Pharma Inc (BBIO) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Tripadvisor Inc Common Stock — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Tripadvisor Inc Common Stock trades at $11.04 (market cap $1.28B). The key difference: BridgeBio Pharma Inc is far larger — about 12.8× Tripadvisor Inc Common Stock's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals.
| BBIO | TRIP | |
|---|---|---|
Market Cap | $16.36B | $1.28B |
Sector | Health | Consumer Cyclical |
52-Week High | $90.17 | $19.14 |
52-Week Low | $47.29 | $9.24 |
Enterprise Value | $18.14B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
